Preventive and Pharmacological Interventions for Stroke: A Narrative Review of Evidence, Challenges, and Future Directions
DOI:
https://doi.org/10.64074/jorma005Keywords:
Stroke prevention, Hypertension, Smoking cessation, Antiplatelet therapy, AnticoagulantsAbstract
Stroke remains one of the leading causes of death and long-term disability worldwide, exerting a significant burden on individuals, healthcare systems, and economies. Preventive strategies are critical in reducing the incidence and recurrence of stroke, especially among populations at high risk due to modifiable and non-modifiable factors. This narrative review synthesizes current evidence on pharmacological and non-pharmacological interventions aimed at stroke prevention. It begins by examining key modifiable risk factors, such as hypertension, smoking, excessive alcohol consumption, and physical inactivity. Hypertension, in particular, is highlighted as the most impactful risk factor, with studies showing that even modest reductions in blood pressure can significantly decrease stroke risk. Similarly, smoking cessation and regular physical activity are strongly associated with a reduced likelihood of stroke events. The review also explores pharmacological measures, including antiplatelet and anticoagulant therapies. Aspirin remains a widely used antiplatelet agent, especially in secondary prevention, although its efficacy must be balanced against potential bleeding risks. Alternatives like clopidogrel and combinations such as dual antiplatelet therapy (DAPT) are examined considering recent clinical trial evidence. In patients with atrial fibrillation, anticoagulants such as warfarin and newer direct oral anticoagulants (DOACs) like apixaban have demonstrated effectiveness in reducing stroke risk with varying safety profiles. This review identifies ongoing challenges, including patient adherence, personalized therapy decisions, and the need for broader public health implementation of preventive strategies. It concludes by highlighting the importance of integrating lifestyle interventions with individualized pharmacological treatments to optimise stroke prevention. Further research is recommended to refine these strategies and address existing gaps in knowledge, particularly in low-resource settings where the stroke burden continues to rise.
References
Adeniji, O., Olowoyo, P., Akinyemi, R., Fisher, M., & Owolabi, M. (2023). Advances in Primordial, Primary, and Secondary Prevention of Stroke in Diverse Populations. Stroke, https://doi.org/10.1161/STROKEAHA.123.044231
Akyea, R., Vinogradova, Y., Qureshi, N., Patel, R., Kontopantelis, E., Ntaios, G., Asselbergs, F., Kai, J., & Weng, S. (2021). Sex, Age, and Socioeconomic Differences in Nonfatal Stroke Incidence and Subsequent Major Adverse Outcomes. Stroke, 52, 396 - 405. https://doi.org/10.1161/STROKEAHA.120.031659.
Li, L., Scott, C., & Rothwell, P. (2020). Trends in Stroke Incidence in High-Income Countries in the 21st Century. Stroke, 51, 1372 - 1380. https://doi.org/10.1161/STROKEAHA.119.028484.
Al-Khatib SM, Mulder H, Wojdyla D, Lopes RD, Wallentin L, Alexander JH, Hijazi Z, Goto S, Granger CB., (2021) Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy: Insights From the ARISTOTLE Trial. Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009614. doi: 10.1161/CIRCEP.120.009614. Epub 2021 Mar 4. PMID: 33657831.
Benz, A.P., Johansson, I., Dewilde, W.J., Lopes, R.D., Mehran, R., Sartori, S., Sarafoff, N., Yasuda, S., McIntyre, W.F., Healey, J.S. and Shoamanesh, A., (2022). Antiplatelet therapy in patients with atrial fibrillation: a systematic review and meta-analysis of randomized trials. European Heart Journal-Cardiovascular Pharmacotherapy, 8(7), pp.648-659.
Brennan, S. E., McDonald, S., Page, M. J., Reid, J., Ward, S., Forbes, A. B., & McKenzie, J. E. (2020). Long-term effects of alcohol consumption on cognitive function: a systematic review and dose-response analysis of evidence published between 2007 and 2018. Systematic Reviews, 9, 33. https://doi.org/10.1186/s13643-019-1220-4.
Carnicelli, A.P., Hong, H., Connolly, S.J., Eikelboom, J., Giugliano, R.P., Morrow, D.A., Patel, M.R., Wallentin, L., Alexander, J.H., Cecilia Bahit, M. and Benz, A.P., (2022). Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. Circulation, 145(4), pp.242-255.
Castrichini, M., Luzum, J.A. and Pereira, N., (2023). Pharmacogenetics of antiplatelet therapy. Annual review of pharmacology and toxicology, 63(1), pp.211-229.
Centers for Disease Control and Prevention (2024). About Surgeon General's Reports on Smoking and Tobacco Use, Available at: https://www.cdc.gov/tobacco-surgeon-general-reports/about/index.html, [Accessed: 26 April 2025].
Centers for Disease Control and Prevention (2025a). Alcohol Use and Your Health. Available at: https://www.cdc.gov/alcohol/about-alcohol-use/index.html, [Accessed: 26 April 2025].
Centers for Disease Control and Prevention (2025b). Preventing Stroke. Available at: https://www.cdc.gov/stroke/prevention/index.html, [Accessed: 26 April 2025]
Centers for Disease Control and Prevention. (2022). Stroke Facts. Available at: https://www.cdc.gov/stroke/data-research/facts-stats/?CDC_AAref_Val=https://www.cdc.gov/stroke/facts.htm, [Accessed: 25 April 2025].
Cleland, J.G., (2022). Aspirin for primary and secondary prevention of cardiovascular disease: time to stop?. Thrombosis and Haemostasis, 122(03), pp.311-314.
Davidson, K.W., Barry, M.J., Mangione, C.M., Cabana, M., Chelmow, D., Coker, T.R., Davis, E.M., Donahue, K.E., Jaén, C.R., Krist, A.H. and Kubik, M., (2022). Aspirin use to prevent cardiovascular disease: US Preventive Services Task Force recommendation statement. Jama, 327(16), pp.1577-1584.
De Santis, F., Romoli, M., Foschi, M., Sciancalepore, F.D., D'Anna, L., Barba, L., Abu-Rumeileh, S., Sacco, S. and Ornello, R., (2024). Risk of stroke with different levels of leisure-time physical activity: a systematic review and meta-analysis of prospective cohort studies. Journal of Neurology, Neurosurgery & Psychiatry, 95(6), pp.504-514.
Ding, C., Yuan, M., Cheng, J. and Wen, J., 2025. Cross-sectional study on smoking types and stroke risk: development of a predictive model for identifying stroke risk. Frontiers in Physiology, 16, p.1528910.
Ettehad D, Emdin CA, Kiran A, et al., (2016) Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016;387(10022):957–967.
Feigin, V.L., Vos, T., Nair, B.S., Hay, S.I., Abate, Y.H., Abd Al Magied, A.H., Abd ElHafeez, S., Abdelkader, A., Abdollahifar, M.A., Abdullahi, A. and Aboagye, R.G., (2025). Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Public Health, 10(3), pp.e203-e227.
Galiuto L and Patrono C., (2021) Challenging the Role of Aspirin for Long-Term Antiplatelet Therapy? Eur Heart J. 2021 Aug 7;42(30):2883-2884. doi: 10.1093/eurheartj/ehab387. PMID: 34179976.
George, M. G., Fischer, L., Koroshetz, W., Bushnell, C., Frankel, M., Foltz, J., & Thorpe, P. G. (2017). CDC Grand Rounds: Public Health Strategies to Prevent and Treat Strokes. MMWR Morbidity and Mortality Weekly Report, 66(18), 479-481. https://www.cdc.gov/mmwr/volumes/66/wr/mm6618a5.htm
Global Burden of Disease Study. (2021). Global Burden of Disease Study 2021 Results. Available at: http://ghdx.healthdata.org/gbd-results-tool, [Accessed: 25 April 2025].
Harvard Health (2024). Does drinking alcohol raise the risk of stroke? Available at: https://www.health.harvard.edu/heart-health/does-drinking-alcohol-raise-the-risk-of-stroke, [Accessed: 26 April 2025].
Jeong, W., (2025). Effect of regular exercise on stroke prevention: an instrumental variables approach. BMC Public Health, 25(1), p.1167.
Karoly, H. C., Kirk-Provencher, K. T., & Gowin, J. L. (2024). Alcohol and brain structure across the lifespan: A systematic review of large-scale neuroimaging studies. Addiction Biology. https://doi.org/10.1111/adb.13439.
Kato, Y., Tsutsui, K., Nakano, S., Hayashi, T. and Suda, S., (2024). Cardioembolic Stroke: past advancements, current challenges, and future directions. International Journal of Molecular Sciences, 25(11), p.5777.
Khan, M., Wasay, M., O'Donnell, M.J., Iqbal, R., Langhorne, P., Rosengren, A., Damasceno, A., Oguz, A., Lanas, F., Pogosova, N. and Alhussain, F., (2023). Risk factors for stroke in the young (18–45 Years): a case-control analysis of INTERSTROKE data from 32 countries. Neuroepidemiology, 57(5), pp.275-283.
Kienzle, T., Aduboffour, A. O., Matasic, D., Burka, S., & Blumenthal, R. S. (2024). New Blood Pressure Target For Individuals at High Risk. American College of Cardiology. Available at: https://www.acc.org/latest-in-cardiology/articles/2024/11/05/11/55/new-blood-pressure-target-for-individuals-at-high-risk, [Accessed: 26 April 2025].
Li, Z.X., Xiong, Y., Gu, H.Q., Fisher, M., Xian, Y., Johnston, S.C. and Wang, Y.J., (2021). P2Y12 inhibitors plus aspirin versus aspirin alone in patients with minor stroke or high-risk transient ischemic attack. Stroke, 52(7), pp.2250-2257.
Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, Lane DA, Ruff CT, Turakhia M, Werring D, Patel S, Moores L., (2018) Antithrombotic Therapy for Atrial Fibrillation: CHEST Guideline and Expert Panel Report. Chest. 2018 Nov;154(5):1121-1201. https://doi.org/10.1016/j.chest.2018.07.040.
Livingstone, K., Abbott, G., Ward, J., & Bowe, S. (2021). Unhealthy Lifestyle, Genetics and Risk of Cardiovascular Disease and Mortality in 76,958 Individuals from the UK Biobank Cohort Study. Nutrients, 13. https://doi.org/10.3390/nu13124283.
Martin, S.S., Aday, A.W., Allen, N.B., Almarzooq, Z.I., Anderson, C.A., Arora, P., Avery, C.L., Baker-Smith, C.M., Bansal, N., Beaton, A.Z. and Commodore-Mensah, Y., (2025). 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation.
Martin, S.S., Aday, A.W., Almarzooq, Z.I., Anderson, C.A., Arora, P., Avery, C.L., Baker-Smith, C.M., Barone Gibbs, B., Beaton, A.Z., Boehme, A.K. and Commodore-Mensah, Y., (2024) 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation, 149(8), pp.e347-e913.
NHS England. (2024). Stroke Statistics. Available at: https://www.england.nhs.uk/statistics/stroke/, [Accessed: 25 April 2025].
Njohjam, M.N., Falonne, N.T. & Ngoule, M.O. Barriers to medication adherence for secondary stroke prevention in rural communities in Cameroon: a qualitative study. BMC Prim. Care 26, 125 (2025). https://doi.org/10.1186/s12875-025-02842-w.
Ortega-Paz, L., A. Cader, I. Cigalini, and D. Giacoppo, (2023) Dual antiplatelet therapy for the general cardiologist: recent evidence, balancing ischaemic and bleeding risk. European Society of Cardiology. Available at: https://www.escardio.org/Councils/Council-for-Cardiology-Practice-(CCP)/Cardiopractice/dual-antiplatelet-therapy-for-the-general-cardiologist-recent-evidence-balanci, [Accessed: 26 April 2025]
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL., (2019) Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019 Dec;50(12):e344-e418. https://doi.org/10.1161/STR.0000000000000211.
Public Health England (2019) Available at: https://www.gov.uk/government/publications/health-matters-preventing-cardiovascular-disease/health-matters-preventing-cardiovascular-disease, [Accessed: 25 April 2025].
Saad, A., Cherian, L. and Benameur, K., (2024). Lifestyle factors and stroke prevention: from the individual to the community. Current neurology and neuroscience reports, 24(10), pp.507-515.
Saad, A., Cherian, L. and Benameur, K., (2024). Lifestyle factors and stroke prevention: from the individual to the community. Current neurology and neuroscience reports, 24(10), pp.507-515.
Sabia, S., Fayosse, A., Dumurgier, J., Dugravot, A., Akbaraly, T., Britton, A., Kivimäki, M., & Singh-Manoux, A. (2018). Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study. BMJ, 362, k2927. https://doi.org/10.1136/bmj.k2927.
Schrage, T., Glissmann, C., Thomalla, G., Rimmele, D.L., Schmidt, H., Rosenkranz, M., Boskamp, S., Härter, M. and Kriston, L., (2025). Process evaluation of a cross-sectoral, coordinated follow-up care of stroke patients: a qualitative study. Neurological Research and Practice, 7(1), p.4.
Smyth, A., O'Donnell, M., Rangarajan, S., Hankey, G.J., Oveisgharan, S., Canavan, M., McDermott, C., Xavier, D., Zhang, H., Damasceno, A. and Avezum, A., (2023). Alcohol intake as a risk factor for acute stroke: the INTERSTROKE study. Neurology, 100(2), pp.e142-e153.
Tornyos D, Komócsi A, Bálint A, Kupó P, El Abdallaoui OEA, Szapáry L, Szapáry LB., (2022) Antithrombotic therapy for secondary prevention in patients with stroke or transient ischemic attack: A multiple treatment network meta-analysis of randomized controlled trials. PLoS One. 2022 Aug 17;17(8):e0273103. https://doi.org/10.1371/journal.pone.0273103.
Valgimigli, M., Frigoli, E., Heg, D., Tijssen, J., Jüni, P., Vranckx, P., Ozaki, Y., Morice, M.C., Chevalier, B., Onuma, Y. and Windecker, S., (2021). Dual antiplatelet therapy after PCI in patients at high bleeding risk. New England Journal of Medicine, 385(18), pp.1643-1655.
Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, Wang C, Li H, Meng X, Cui L, Jia J, Dong Q, Xu A, Zeng J, Li Y, Wang Z, Xia H, Johnston SC; CHANCE Investigators. (2013) Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013 Jul 4;369(1):11-9. https://doi.org/10.1056/NEJMoa1215340.
World Health Organization. (2022). Stroke: A Global Perspective. Available at: https://www.who.int/news-room/fact-sheets/detail/stroke, [Accessed: 26 April 2025].
Yu, D., Li, J-x., Cheng, Y., Wang, H-d., Ma, X-d., Ding, T., & Zhu, Z-n. (2025). Comparative efficacy of different antihypertensive drug classes for stroke prevention: A network meta-analysis of randomized controlled trials. PLOS ONE, 20(2), e0313309. https://doi.org/10.1371/journal.pone.0313309
Zeng, S., Zheng, Y., Jiang, J., Ma, J., Zhu, W. and Cai, X., (2022). Effectiveness and safety of DOACs vs. warfarin in patients with atrial fibrillation and frailty: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 9, p.907197.
Zhao, B., Wu, Q., Wang, L., Liao, C., Dong, Y., Xu, J., Wei, Y. and Zhang, W., (2021). Pros and cons of aspirin for the primary prevention of cardiovascular events: a secondary study of trial sequential analysis. Frontiers in pharmacology, 11, p.592116.
